Ph.D., VP of Americas, Aiforia Inc.
Biography
Dr. Thomas Westerling-Bui received his PhD in cancer biology, focusing on the cell cycle and transcription, from the University of Helsinki Medical School in Finland. He completed a post-doctoral EMBO fellowship at the Dana Farber Cancer Institute in Boston, researching the genomics of breast and prostate cancer. Thomas joined Aiforia to advance the new potential of cancer biology, pathology, big data, and artificial intelligence.
Session Abstract – PMWC 2023 Silicon Valley
Track 2 - January 25 9.00 A.M.-4.30 P.M.
Track Co-Chairs:
Russ Cucina, UCSF
- How can AI and Data Science Determine Which Patients should be Preemptively Tested? (PANEL)
Chair: Russ Cucina, UCSF
- Lisa Kroon, UCSF
- Sylvia Plevritis, Stanford
- Eran Segal, WI
- Daniel Knecht, CVS Health - Establishing Genomics in the Clinic as a Routine Requires AI and Automation
Chair: Bani Tamraz, UCSF
- Sergio Baranzini, UCSF
- James Shalaby, Elimu Informatics - Representation and Equity in Genomic Data
Chair: Karen Miga, UCSC
- Timothy Rebbeck, Harvard
- Keolu Fox, UC San Diego
- Malcolm John, UCSF - Overcoming Barriers to Bringing Multi-omic's into Clinical Practices
Chair: Russ Cucina, UCSF
- Peter DeVault, Epic
- Kevin Hass, Myriad
- Jim Chen, Tempus
- Amie Blanco, UCSF - Misaligned Incentives Across Public-Private Partnerships in Patient Health (PANEL)
Chair: Justin Wildsmith, Syntropy
- Steve Goldstein, UC Irvine
- Ken Harris, AWS
- Suzanne George, Dana Farber Cancer Institute
- Nelson D’Antonio, Palantir - From Code to the Clinic: A Framework for the Ethical Integration of Precision AI into Healthcare
- Lisa Lehmann, Google - PMWC Showcase:
- Thomas Westerling-Bui, Aiforia Inc.
- Amrie Grammer, Ampel Bio Solutions
- Liat Dassa, CytoReason
- Ryan Ahern, Truveta
